![](/img/cover-not-exists.png)
The anti-tumoral drug enzastaurin inhibits natural killer cell cytotoxicity via activation of glycogen synthase kinase-3β
Henry Ogbomo, Tsigereda Biru, Martin Michaelis, Nadine Loeschmann, Hans Wilhelm Doerr, Jindrich Cinatl Jr.Volume:
81
Year:
2011
Language:
english
Pages:
8
DOI:
10.1016/j.bcp.2010.09.026
File:
PDF, 466 KB
english, 2011